Evidence map›Paper›PMID 35686436›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021-January 2022.

Renee D Wegrzyn, Grace D Appiah, Robert Morfino, Scott R Milford, Allison Taylor Walker, Ezra T Ernst, William W Darrow, Siyao Lisa Li, Keith Robison, Duncan MacCannell and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Renee D WegrzynGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Grace D AppiahDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Robert MorfinoGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Scott R MilfordXpresCheck™, XpresSpa™, New York, NY, USA.
Allison Taylor WalkerDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ezra T ErnstXpresCheck™, XpresSpa™, New York, NY, USA.
William W DarrowXpresCheck™, XpresSpa™, New York, NY, USA.
Siyao Lisa LiGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Keith RobisonGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Duncan MacCannellOffice of Advanced Molecular Detection, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dongjuan DaiGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Brintha P GirinathanGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Allison L HicksGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Bryan CoscaGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Gabrielle WoronoffGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Alex M PlocikGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Birgitte B SimenGinkgo Bioworks, Inc, Boston, Massachusetts, USA.
Leah MoriartyDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sarah Anne J GuagliardoDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Martin S CetronDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cindy R FriedmanDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ginkgo BioWorks (United States) · USCenters for Disease Control and Prevention · US

Funding

CDC
6 · The paper itself

Abstract

We enrolled arriving international air travelers in a severe acute respiratory syndrome coronavirus 2 genomic surveillance program. We used molecular testing of pooled nasal swabs and sequenced positive samples for sublineage. Traveler-based surveillance provided early-warning variant detection, reporting the first US Omicron BA.2 and BA.3 in North America.

Indexed as

COVID-19SARS-CoV-2AirportsGenomicsHumansgenomic surveillanceinternational travelersSARS-CoV-2

Identifiers

PMID35686436
PMCPMC9214179
OpenAlexW4281653060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.